08:00 , Dec 20, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Sarcoma Insulin-like growth factor 1 receptor (IGF1R; CD221); arrestin b1 (ARRB1); MAPK (ERK)...
07:00 , Apr 7, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Pulmonary disease Pulmonary fibrosis Arrestin b1 (ARRB1); ARRB2 In vitro and mouse studies suggest that inhibition of...
07:00 , Apr 16, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Metabolic disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Metabolic disease ...
07:00 , Mar 26, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cardiovascular disease Myocardial infarction...
08:00 , Feb 19, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/ marker/pathway Summary Licensing status Publication and contact information Cancer ...